CellSeed, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423530009
JPY
287.00
-229 (-44.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Poor long term growth as Net Sales has grown by an annual rate of -0.35% and Operating profit at -5.46% over the last 5 years

 
3

The company declared very negative results in Mar'25 after flat results in Dec'24

4

Risky - Negative EBITDA

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 12,125 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.94

stock-summary
Return on Equity

-76.55%

stock-summary
Price to Book

9.25

Revenue and Profits:
Net Sales:
28 Million
(Quarterly Results - Sep 2025)
Net Profit:
-198 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.85%
0%
-22.85%
6 Months
-40.46%
0%
-40.46%
1 Year
20.59%
0%
20.59%
2 Years
-10.31%
0%
-10.31%
3 Years
83.97%
0%
83.97%
4 Years
24.78%
0%
24.78%
5 Years
-38.68%
0%
-38.68%

CellSeed, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.35%
EBIT Growth (5y)
-5.46%
EBIT to Interest (avg)
-668.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.08
Tax Ratio
0.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.57
EV to EBIT
-16.80
EV to EBITDA
-16.80
EV to Capital Employed
-1350.62
EV to Sales
90.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-57.20%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 177.45% vs -61.94% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 22.96% vs 34.62% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.30",
          "val2": "10.20",
          "chgp": "177.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-201.30",
          "val2": "-230.70",
          "chgp": "12.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.70",
          "val2": "-26.20",
          "chgp": "110.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-198.30",
          "val2": "-257.40",
          "chgp": "22.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7,123.40%",
          "val2": "-22,652.60%",
          "chgp": "1,552.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.68% vs 50.40% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.57% vs -11.43% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "193.30",
          "val2": "190.10",
          "chgp": "1.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-846.40",
          "val2": "-555.60",
          "chgp": "-52.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.10",
          "val2": "1.10",
          "chgp": "90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.90",
          "val2": "-151.10",
          "chgp": "93.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-859.80",
          "val2": "-846.50",
          "chgp": "-1.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,379.10%",
          "val2": "-2,964.10%",
          "chgp": "-141.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
28.30
10.20
177.45%
Operating Profit (PBDIT) excl Other Income
-201.30
-230.70
12.74%
Interest
0.50
0.50
Exceptional Items
2.70
-26.20
110.31%
Consolidate Net Profit
-198.30
-257.40
22.96%
Operating Profit Margin (Excl OI)
-7,123.40%
-22,652.60%
1,552.92%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 177.45% vs -61.94% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 22.96% vs 34.62% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
193.30
190.10
1.68%
Operating Profit (PBDIT) excl Other Income
-846.40
-555.60
-52.34%
Interest
2.10
1.10
90.91%
Exceptional Items
-9.90
-151.10
93.45%
Consolidate Net Profit
-859.80
-846.50
-1.57%
Operating Profit Margin (Excl OI)
-4,379.10%
-2,964.10%
-141.50%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 1.68% vs 50.40% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -1.57% vs -11.43% in Dec 2023

stock-summaryCompany CV
About CellSeed, Inc. stock-summary
stock-summary
CellSeed, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available